PRISMA: Toward a Normative Information Infrastructure for Responsible Pharmaceutical Knowledge Management

arXiv cs.AI / 3/30/2026

💬 OpinionDeveloper Stack & InfrastructureIdeas & Deep Analysis

Key Points

  • The paper argues that many AI-in-pharmacy systems inappropriately merge document preservation, semantic interpretation, and contextual presentation into one layer, leading to provenance loss, opaque interpretation, alert fatigue, and weakened accountability.
  • It proposes a normative information infrastructure (PATOS–Lector–PRISMA) where regulatory documents are preserved with explicit versioning/provenance, machine-assisted reading is paired with human curation to produce typed, source-anchored assertions, and presentation is refracted into role-specific views via the RPDA framework.
  • The authors introduce an “Evidence Pack” as a formal, accountable unit of assertions that is versioned, traceable, epistemically bounded, and curatorially validated, with assertions typified by illocutionary force to clarify intent.
  • A worked example traces dipyrone monohydrate across all layers using real system data, and the architecture is validated in Brazil with an operational implementation covering 16,000+ official documents and 38 curated Evidence Packs for five reference medications.
  • The work positions the infrastructure as complementary to existing clinical/operational decision support systems by adding documentary anchoring, interpretive transparency, and institutional accountability that current tools often lack.

Abstract

Most existing approaches to AI in pharmacy collapse three epistemologically distinct operations into a single technical layer: document preservation, semantic interpretation, and contextual presentation. This conflation is a root cause of recurring fragilities including loss of provenance, interpretive opacity, alert fatigue, and erosion of accountability. This paper proposes the PATOS--Lector--PRISMA (PLP) infrastructure as a normative information architecture for responsible pharmaceutical knowledge management. PATOS preserves regulatory documents with explicit versioning and provenance; Lector implements machine-assisted reading with human curation, producing typed assertions anchored to primary sources; PRISMA delivers contextual presentation through the RPDA framework (Regulatory, Prescription, Dispensing, Administration), refracting the same informational core into distinct professional views. The architecture introduces the Evidence Pack as a formal unit of accountable assertion (versioned, traceable, epistemically bounded, and curatorially validated), with assertions typified by illocutionary force. A worked example traces dipyrone monohydrate across all three layers using real system data. Developed and validated in Brazil's regulatory context, the architecture is grounded in an operational implementation comprising over 16,000 official documents and 38 curated Evidence Packs spanning five reference medications. The proposal is demonstrated as complementary to operational decision support systems, providing infrastructural conditions that current systems lack: documentary anchoring, interpretive transparency, and institutional accountability.